Cargando…
Assessment of the safety and probiotic properties of Roseburia intestinalis: A potential “Next Generation Probiotic”
Roseburia intestinalis is an anaerobic bacterium that produces butyric acid and belongs to the phylum Firmicutes. There is increasing evidence that this bacterium has positive effects on several diseases, including inflammatory bowel disease, atherosclerosis, alcoholic fatty liver, colorectal cancer...
Autores principales: | Zhang, Chao, Ma, Kejia, Nie, Kai, Deng, Minzi, Luo, Weiwei, Wu, Xing, Huang, Yujun, Wang, Xiaoyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9493362/ https://www.ncbi.nlm.nih.gov/pubmed/36160246 http://dx.doi.org/10.3389/fmicb.2022.973046 |
Ejemplares similares
-
Roseburia intestinalis: A Beneficial Gut Organism From the Discoveries in Genus and Species
por: Nie, Kai, et al.
Publicado: (2021) -
Roseburia intestinalis stimulates TLR5-dependent intestinal immunity against Crohn's disease
por: Shen, Zhaohua, et al.
Publicado: (2022) -
Roseburia intestinalis supernatant ameliorates colitis induced in mice by regulating the immune response
por: Luo, Weiwei, et al.
Publicado: (2019) -
Roseburia intestinalis inhibits interleukin-17 excretion and promotes regulatory T cells differentiation in colitis
por: Zhu, Changxin, et al.
Publicado: (2018) -
Roseburia intestinalis-derived flagellin ameliorates colitis by targeting miR-223-3p-mediated activation of NLRP3 inflammasome and pyroptosis
por: Wu, Xing, et al.
Publicado: (2020)